Research suggests that bacteria inside tumors can suppress the immune system and contribute to resistance to immunotherapy in certain types of cancer, including head and neck cancer. The presence of higher levels of bacteria in tumors may weaken the immune response, although the specific mechanisms and implications are still being studied. The relationship between intratumoral bacteria and cancer treatment outcomes is being explored in various types of cancer, including colorectal, pancreatic, and hepatocellular carcinoma.